Merck
MRK
#40
Rank
S$451.71 B
Marketcap
S$183.09
Share price
-0.15%
Change (1 day)
77.17%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$4.58

According to Merck's latest financial reports the company's current EPS (TTM) is S$4.55. In 2025 the company made an earnings per share (EPS) of S$9.31 an increase over its 2024 EPS that were of S$8.61.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.58-50.79%
2025S$9.318.15%
2024S$8.614308.46%
2023S$0.20-97.32%
2022S$7.3010.92%
2021S$6.5884.68%
2020S$3.56-27.2%
2019S$4.8963.44%
2018S$2.99151.11%
2017S$1.19-54.58%
2016S$2.6230.21%
2015S$2.02-61.99%
2014S$5.30180.51%
2013S$1.89-31.82%
2012S$2.776.62%
2011S$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.12 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.94 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.67-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.59 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.94 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.44 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.26-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$4.53-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.95 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.74-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel